{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-061230","form_type":"8-K","ticker":"PTPI","cik":"0001815903","company_name":"Petros Pharmaceuticals, Inc.","filed_at":"2025-06-20T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.842933+00:00","generated_at":"2026-05-19T01:42:42.763608+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"Petros Pharmaceuticals assigns subsidiary assets (Metuchen, Timm, Pos-T-Vac) to creditor trust","bullets":["Effective June 16, 2025, Petros assigned all assets of subsidiaries Metuchen, Timm Medical, and Pos-T-Vac to a third-party fiduciary for benefit of creditors.","The Vivus License Agreement for Stendra® was terminated March 31, 2025; Petros lost all rights to Stendra in the Licensed Territory.","Pro forma balance sheet shows stockholders' equity of $8.0M as of March 31, 2025, reflecting deconsolidation, warrant exercises, and redemptions.","Subsidiaries' operations classified as discontinued; deconsolidation from Petros' balance sheet expected in Q2 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-061230","json":"https://secwatch.observer/filing/0001104659-25-061230.json","markdown":"https://secwatch.observer/filing/0001104659-25-061230.md","text":"https://secwatch.observer/filing/0001104659-25-061230.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1815903/000110465925061230/0001104659-25-061230-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1815903/000110465925061230/tm2518572d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T01:42:42.763608+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}